Bertolini Jeffrey sold $11K of CARL
Bertolini Jeffrey (Chief Operating Officer) sold 747 shares of CARLSMED, INC. (CARL) at $14.39 on 2026-10-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is small and likely to have limited price impact.
Market read
Routine insider transaction with modest size; low trading relevance.
What to watch
Potential upcoming corporate events not disclosed may influence future insider activity.
Background
CARLSMED, INC. (CARL) filed a Form 4 reporting an insider sale by its COO under a 10b5‑1 plan.
Ticker impact
Form 4 shows COO sold 747 shares for $10.7K via 10b5-1 plan, reducing holdings to 22,489 shares.
likely slight pressure as market prices in the small insider sale
The sale amount is modest and disclosed via a pre‑arranged plan, so impact is limited.
Market effects
None significant for the broader healthcare sector.
No regional effect.
Minimal.
Counterpoint
The sale could be routine and not indicative of any negative outlook.
Key entities
- OfficerBertolini Jeffrey
Chief Operating Officer of CARLSMED, INC.